Clinical studies of extended-half-life recombinant FVIII products for prophylaxis in adults and children: A critical review from the physician's perspective.

Hermans, Cedric; Reding, Mark T; Astermark, Jan; Klamroth, Robert; Mancuso, Maria Elisa

Hermans, Cedric; Reding, Mark T; Astermark, Jan; Klamroth, Robert; Mancuso, Maria Elisa.

Afiliação

Hermans C; Cliniques Universitaires Saint-Luc, Division of Haematology, Université Catholique de Louvain (UCLouvain), Belgium. Electronic address: cedric.hermans@uclouvain.be.
Reding MT; Center for Bleeding and Clotting Disorders, University of Minnesota Medical Center, USA.
Astermark J; Centre for Thrombosis and Haemostasis and Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden.
Klamroth R; Vivantes Hospital, Friedrichshain, Berlin, Germany.
Mancuso ME; Center for Thrombosis and Hemorrhagic Diseases, IRCCS Humanitas Clinical and Research Center, Rozzano, Milan, Italy.

Crit Rev Oncol Hematol ; 174: 103678, 2022 Jun.

Article em En | MEDLINE | ID: mdl-35390452

Assuntos

Hemofilia A; Médicos; Adulto; Criança; Fator VIII/uso terapêutico; Meia-Vida; Hemofilia A/tratamento farmacológico; Humanos; Proteínas Recombinantes/uso terapêutico

Palavras-chave

Extended-half-life; Factor VIII; Fc fusion; Hemophilia A; Polyethylene glycol; Prophylaxis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Médicos / Hemofilia A Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Médicos / Hemofilia A Idioma: En Ano de publicação: 2022 Tipo de documento: Article